Código QR

Comparative efficacy and safety of apixaban and rivaroxaban versus warfarin in atrial fibrillation patients with end-stage renal disease: a systematic review and meta-analysis

This study aimed to evaluate the comparative efficacy and safety of apixaban and rivaroxaban versus vitamin K antagonists (VKAs) in anticoagulation management in a dialysis population. PubMed, Embase, and the Cochrane Library were searched for studies comparing apixaban or rivaroxaban with VKAs in p...

Descrición completa

Gardado en:
Principais autores: Xiaoyuan Wu, Jie Meng, Yu Yang, Dacheng Sheng, Xin Liu, Yilun Zhou
Formato: Artigo
Idioma:Inglês
Publicado: Taylor & Francis Group 2026-12-01
Series:Renal Failure
Assuntos:
Apixaban
rivaroxaban
atrial fibrillation
end-stage renal disease
dialysis
Acceso en liña:https://www.tandfonline.com/doi/10.1080/0886022X.2026.2666454
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares